Live Breaking News & Updates on Puerta De Hierro Majadahonda University Hospital Spain

Stay updated with breaking news from Puerta de hierro majadahonda university hospital spain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scientists find new therapeutic approach to effectively treat age-related macular degeneration

Scientists find new therapeutic approach to effectively treat age-related macular degeneration
Runt-related transcription factor 1 (RUNX1) has been linked to retinal neovascularization and the development of abnormal blood vessels, which result in vision loss in diabetic retinopathy. Now, scientists have found that RUNX1 inhibition presents a new therapeutic approach in the treatment of age-related macular degeneration (AMD), which is the leading cause of blindness in the elderly worldwide. Their results are reported in
The American Journal of Pathology, published by Elsevier.
Abnormal growth of blood vessels, or aberrant angiogenesis, arises from the choroid, a part of the eye located behind the retina. This condition, known as choroidal neovascularization (CNV), is present in several ocular diseases that lead to blindness such as AMD. This study is the first to implicate RUNX1 in CNV and to test RUNX1 inhibition therapy for treating CNV. Researchers found that appli ....

United States , Leoa Kim , Lucia Gonzalez Buendia , Josephf Arboleda Velasquez , Emily Henderson , Schepens Eye Research Institute Of Mass , Puerta De Hierro Majadahonda University Hospital Spain , Harvard Medical School , Department Of Ophthalmology , American Journal , Puerta De Hierro Majadahonda University Hospital , Schepens Eye Research Institute , Mass Eye , Drug Administration Approved , Aassistant Scientist , Assistant Professor , Age Related Macular Degeneration , Macular Degeneration , Blood Vessels , Diabetic Retinopathy , Medical School , Vision Loss , ஒன்றுபட்டது மாநிலங்களில் , லூசியா கோன்சலஸ் பியூண்டியா , எமிலி ஹென்டர்சன் , திட்டங்கள் கண் ஆராய்ச்சி நிறுவனம் ஆஃப் நிறை ,

New therapeutic approach may help treat age-related macular degeneration effectively

Runt-related transcription factor 1 (RUNX1) has been linked to retinal neovascularization and the development of abnormal blood vessels, which result in vision loss in diabetic retinopathy. Now, scientists have found that RUNX1 inhibition presents a new therapeutic approach in the treatment of age-related macular degeneration (AMD), which is the leading cause of blindness in the elderly worldwide. Their results are reported in The American Journal of Pathology, published by Elsevier. ....

United States , Leoa Kim , Lucia Gonzalez Buendia , Josephf Arboleda Velasquez , Schepens Eye Research Institute Of Mass , Puerta De Hierro Majadahonda University Hospital Spain , Harvard Medical School , Department Of Ophthalmology , American Journal , Puerta De Hierro Majadahonda University Hospital , Schepens Eye Research Institute , Mass Eye , Drug Administration Approved , Aassistant Scientist , Assistant Professor , Medicine Health , Gene Therapy , ஒன்றுபட்டது மாநிலங்களில் , லூசியா கோன்சலஸ் பியூண்டியா , திட்டங்கள் கண் ஆராய்ச்சி நிறுவனம் ஆஃப் நிறை , ஹார்வர்ட் மருத்துவ பள்ளி , துறை ஆஃப் கண் மருத்துவம் , அமெரிக்கன் இதழ் , திட்டங்கள் கண் ஆராய்ச்சி நிறுவனம் , நிறை கண் , உதவியாளர் விஞ்ஞானி ,